Capital Bank & Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Capital Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $11,839 - $15,454	-24 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $1,008 - $1,483	3 Added 14.29%	24 $12,000
Q4 2019 Feb 18, 2020	SELL	$274.13 - $376.51 $1,096 - $1,506	-4 Reduced 16.0%	21 $8,000
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $1,093 - $1,273	4 Added 19.05%	25 $7,000
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $6,291 - $8,711	21 New	21 $7,000

Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $4,737 - $5,906	-15 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $5,379 - $7,049	15	15 $6,000

1,443

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $116B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.